SCHEMBL31340332

SCHEMBL31340332

COCCO[C@H]1CCN(C(=O)OCc2ccccc2)C[C@@H]1NC(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.53
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP2C19 P33261 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
CTSL P07711 1/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NTSR1 P30989 1/20 0.41
KMT2A Q03164 2/20 0.41
HSD11B1 P28845 1/20 0.41
USP30 Q70CQ3 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
GRIN2B Q13224 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31340194 0.92 PDE4B (0.51) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL2518065 0.92 PDE4B (0.55) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL28568774 0.92 PDE4B (0.55) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL28568769 0.92 PDE4B (0.55) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL18247458 0.90 PDE4B (0.53) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL18258160 0.90 PDE4B (0.53) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL376543 0.90 PDE4B (0.53) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL21335664 0.90 PDE4B (0.53) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL376172 0.90 PDE4B (0.56) PDE4BHTTSMN1; SMN2NPC1RAB9A
SCHEMBL20121078 0.90 PDE4B (0.56) PDE4BHTTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747250-A1 KINASE INHIBITORS The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) 2026-05-27 EP disclosed
WO-2025019585-A1 KINASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-23 WO disclosed